Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma

✍ Scribed by Grégory Gatouillat; Emilie Balasse; Débora Joseph-Pietras; Hamid Morjani; Claudie Madoulet

• Book ID: 102876131
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 584 KB
• Volume: 110
• Category: Article
• ISSN: 0730-2312
• DOI: 10.1002/jcb.22601

✦ Synopsis

Abstract

Resveratrol, a naturally occurring polyphenol, has been shown to possess chemopreventive activities. In this study, we show that resveratrol (0–500 µM) inhibits the growth of a doxorubicin‐resistant B16 melanoma cell subline (B16/DOX) (IC~50~ = 25 µM after 72 h, P < 0.05). This was accomplished by imposing an artificial checkpoint at the G~1~–S phase transition, as demonstrated by cell‐cycle analysis and down‐regulation of cyclin D1/cdk4 and increased of p53 expression level. The G~1~‐phase arrest of cell cycle in resveratrol‐treated (10–100 µM) B16/DOX cells was followed by the induction of apoptosis, which was revealed by pyknotic nuclei and fragmented DNA. Resveratrol also potentiated at subtoxic dose (25 µM for 24 h) doxorubicin cytotoxicity in the chemoresistant B16 melanoma (P < 0.01). When administered to mice, resveratrol (12.5 mg/kg) reduced the growth of an established B16/DOX melanoma and prolonged survival (32% compared to untreated mice). All these data support a potential use of resveratrol alone or in combination with other chemotherapeutic agents in the management of chemoresistant tumors. J. Cell. Biochem. 110: 893–902, 2010. © 2010 Wiley‐Liss, Inc.